Clinicopathological features and treatment outcomes of fibrosing alopecia in a pattern distribution: a multicentre cohort study
| dc.contributor.author | Tang G.T. | |
| dc.contributor.author | Triwongwaranat D. | |
| dc.contributor.author | De Souza Teixeira M. | |
| dc.contributor.author | Gavazzoni Dias M.F.R. | |
| dc.contributor.author | Harries M. | |
| dc.contributor.author | Holmes S. | |
| dc.contributor.author | Suchonwanit P. | |
| dc.contributor.author | Saceda-Corralo D. | |
| dc.contributor.author | Boyle A. | |
| dc.contributor.author | Wall D. | |
| dc.contributor.author | Sinclair R. | |
| dc.contributor.author | Gil-Redondo R. | |
| dc.contributor.author | Vañó-Galván S. | |
| dc.contributor.author | Asfour L. | |
| dc.contributor.author | Khobzei K. | |
| dc.contributor.author | Muttoni E. | |
| dc.contributor.author | Nirenberg A. | |
| dc.contributor.author | Bhoyrul B. | |
| dc.contributor.correspondence | Tang G.T. | |
| dc.contributor.other | Mahidol University | |
| dc.date.accessioned | 2026-03-02T18:26:54Z | |
| dc.date.available | 2026-03-02T18:26:54Z | |
| dc.date.issued | 2026-02-24 | |
| dc.description.abstract | BACKGROUND: Fibrosing alopecia in a pattern distribution (FAPD) is a lymphocytic primary cicatricial alopecia first described in 2000. However, to date, the FAPD literature remains sparse. OBJECTIVES: To identify clinicopathological features and treatment outcomes of FAPD in a large multicentre cohort. METHODS: Patients who had biopsy-proven FAPD were selected from nine specialist hair clinics and were reviewed retrospectively to evaluate the clinical pattern of hair loss, trichoscopic and histopathological features, and response to treatment. RESULTS: Of 110 patients, with a mean age of onset of 52.5 (SD 14.8) years, 94 (85.5%) were women. The most common trichoscopic findings were loss of follicular ostia (97.2%, 103/106) and anisotrichia (97%, 84/87). Histopathological examination revealed perifollicular lymphocytic infiltration in 96.1% (99/103) and concentric lamellar fibrosis in 97% (92/95). After a median duration of treatment of 24 [interquartile range (IQR) 13-50] months, there was stabilization in hair density [median Sinclair grade 3.0 (IQR 3.0-4.0) pretreatment vs. 3.0 (IQR 2.0-4.0) post-treatment, P = 0.62]. Out of the 42 patients who received treatment for ≥ 12 months, 23 achieved stabilization and 16 demonstrated improvement in hair density. CONCLUSIONS: Limitations of the study include its retrospective design and disparate treatments. FAPD may be prone to misdiagnosis because of overlapping clinicopathological features with androgenetic alopecia. A combination of anti-inflammatory (for example, topical corticosteroids) and hair growth-promoting agents (for example, topical or low-dose oral minoxidil) can stabilize the condition or even promote hair regrowth. | |
| dc.identifier.citation | Clinical and Experimental Dermatology Vol.51 No.3 (2026) , 411-417 | |
| dc.identifier.doi | 10.1093/ced/llaf444 | |
| dc.identifier.eissn | 13652230 | |
| dc.identifier.pmid | 41066610 | |
| dc.identifier.scopus | 2-s2.0-105030948940 | |
| dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/123456789/115491 | |
| dc.rights.holder | SCOPUS | |
| dc.subject | Medicine | |
| dc.title | Clinicopathological features and treatment outcomes of fibrosing alopecia in a pattern distribution: a multicentre cohort study | |
| dc.type | Article | |
| mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105030948940&origin=inward | |
| oaire.citation.endPage | 417 | |
| oaire.citation.issue | 3 | |
| oaire.citation.startPage | 411 | |
| oaire.citation.title | Clinical and Experimental Dermatology | |
| oaire.citation.volume | 51 | |
| oairecerif.author.affiliation | University of Melbourne | |
| oairecerif.author.affiliation | University of Glasgow | |
| oairecerif.author.affiliation | Universidade Federal Fluminense | |
| oairecerif.author.affiliation | Faculty of Biology, Medicine and Health | |
| oairecerif.author.affiliation | Hospital Universitario Ramón y Cajal | |
| oairecerif.author.affiliation | V. N. Karazin Kharkiv National University | |
| oairecerif.author.affiliation | Siriraj Hospital | |
| oairecerif.author.affiliation | Salford Royal Hospital | |
| oairecerif.author.affiliation | Ramathibodi Hospital | |
| oairecerif.author.affiliation | Mater Misericordiae University Hospital | |
| oairecerif.author.affiliation | UCD School of Medicine | |
| oairecerif.author.affiliation | Chelsea and Westminster Hospital NHS Foundation Trust | |
| oairecerif.author.affiliation | Royal Hospital for Children, Glasgow | |
| oairecerif.author.affiliation | BlackRock, Inc. | |
| oairecerif.author.affiliation | Grupo de Dermatología Pedro Jaén | |
| oairecerif.author.affiliation | Sinclair Dermatology | |
| oairecerif.author.affiliation | Dorevitch Pathology | |
| oairecerif.author.affiliation | Antonio Pedo University Hospital |
